is noom glp 1 safe GLP-1 Review 2026: Great App but Hidden Costs Noom Enters Longevity Health Space

Based on results from the SURMOUNT-OSA trial, investigating tirzepatide in OSA patients with obesity, Eli Lilly submitted a supplemental new drug application to the FDA in June seeking approval for OSA

Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: Exploring the subclinical psoriatic arthritis stage

May 7, 2024 The noise around GLP-1 drugs and their ripple effect on medtech continues to grow louder as clinical data appears to support a growing use case for the drugs

This would be a huge step towards transitioning the medical system away from using opioids for chronic pain, which would reduce harmful side effects and prevent new addictions in patients and via diversion

Not one-size-fits-all